IPW
UTHR icon

Impact Partnership Wealth’s United Therapeutics UTHR Stock Holding History

Impact Partnership Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-974
Closed -$344K – 344
2024
Q4 		$344K Buy
974
+265
+37% +$97.4K 0.07% 182
2024
Q3 		$254K Buy
+709
New +$239K 0.06% 200
2024
Q2 		– Sell
-2
Closed -$459 – 655
2024
Q1 		$459 Sell
2
-479
-100% -$108K ﹤0.01% 656
2023
Q4 		$106K Buy
+481
New +$111K 0.04% 237

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Impact Partnership Wealth's UTHR Position: Q1 2025 in Review

Impact Partnership Wealth sold out of United Therapeutics (UTHR) in Q1 2025, closing a stake of 974 shares — an estimated $344K sold.

Impact Partnership Wealth first reported a position in UTHR in Q4 2023 and held it in 4 quarters. The position peaked at $344K in Q4 2024. 671 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Impact Partnership Wealth reported no remaining United Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Impact Partnership Wealth sold 974 United Therapeutics shares in Q1 2025, an estimated $344K.
  • Impact Partnership Wealth first reported a position in United Therapeutics in Q4 2023 and held it in 4 quarters.
  • Impact Partnership Wealth's United Therapeutics position peaked at $344K in Q4 2024.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Impact Partnership Wealth's 13F filing for Q1 2025, filed 5 May 2025.